Alps Advisors Inc. Purchases Shares of 1,553 Chemed Co. (CHE)

Share on StockTwits

Alps Advisors Inc. purchased a new position in shares of Chemed Co. (NYSE:CHE) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,553 shares of the company’s stock, valued at approximately $496,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in CHE. Fort L.P. purchased a new stake in Chemed during the 2nd quarter worth about $120,000. Cerebellum GP LLC purchased a new stake in Chemed during the 3rd quarter worth about $148,000. Tower Research Capital LLC TRC lifted its holdings in Chemed by 70.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 544 shares of the company’s stock worth $175,000 after buying an additional 224 shares during the last quarter. We Are One Seven LLC purchased a new stake in Chemed during the 3rd quarter worth about $228,000. Finally, Hollencrest Capital Management purchased a new stake in Chemed during the 3rd quarter worth about $231,000. 90.39% of the stock is owned by institutional investors.

A number of analysts have recently commented on CHE shares. Bank of America started coverage on Chemed in a research report on Friday, October 12th. They set a “buy” rating and a $390.00 target price on the stock. Royal Bank of Canada lifted their target price on Chemed to $321.00 and gave the stock a “market perform” rating in a research report on Monday, July 30th. Zacks Investment Research cut Chemed from a “buy” rating to a “hold” rating in a research report on Tuesday, September 25th. Finally, ValuEngine cut Chemed from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 2nd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $334.00.

In related news, insider Kevin J. Mcnamara sold 7,000 shares of the business’s stock in a transaction dated Friday, November 2nd. The stock was sold at an average price of $305.98, for a total value of $2,141,860.00. Following the transaction, the insider now owns 141,293 shares in the company, valued at approximately $43,232,832.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction dated Thursday, August 23rd. The shares were sold at an average price of $319.50, for a total value of $1,278,000.00. Following the completion of the transaction, the insider now owns 139,491 shares in the company, valued at approximately $44,567,374.50. The disclosure for this sale can be found here. Insiders have sold 13,006 shares of company stock worth $4,064,958 in the last quarter. Insiders own 4.82% of the company’s stock.

CHE opened at $313.69 on Wednesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.11 and a current ratio of 1.14. Chemed Co. has a one year low of $227.14 and a one year high of $335.99. The stock has a market cap of $4.94 billion, a PE ratio of 58.52, a PEG ratio of 2.69 and a beta of 1.23.

Chemed (NYSE:CHE) last posted its earnings results on Monday, October 29th. The company reported $3.07 EPS for the quarter, topping the Zacks’ consensus estimate of $2.80 by $0.27. Chemed had a return on equity of 35.13% and a net margin of 11.73%. The business had revenue of $444.15 million for the quarter, compared to analysts’ expectations of $445.16 million. During the same quarter in the previous year, the firm earned $2.15 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Chemed Co. will post 11.41 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, December 3rd. Stockholders of record on Monday, November 12th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date is Thursday, November 8th. Chemed’s dividend payout ratio (DPR) is currently 22.39%.

TRADEMARK VIOLATION WARNING: “Alps Advisors Inc. Purchases Shares of 1,553 Chemed Co. (CHE)” was first published by Macon Daily and is the property of of Macon Daily. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://macondaily.com/2018/11/07/alps-advisors-inc-purchases-shares-of-1553-chemed-co-che.html.

About Chemed

Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Read More: Understanding Relative Strength Index

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply